<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients suffering from a <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> who were admitted to the Neurosurgical Unit of the Royal Perth Hospital during the period 1971 to 1979 were assessed with regard to the effectiveness of preoperative treatment with <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi>, <z:chebi fb="0" ids="6104">kanamycin</z:chebi>, and <z:chebi fb="0" ids="28487">reserpine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-two patients who were treated with <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi> had a rebleed rate of 2.3% compared to 1 9.7% rebleed rate in appropriately selected controls </plain></SENT>
<SENT sid="2" pm="."><plain>Patients treated with <z:chebi fb="0" ids="6104">kanamycin</z:chebi> and <z:chebi fb="0" ids="28487">reserpine</z:chebi> had a preoperative <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> rate of 32% compared to a 26% rate in controls; however, <z:chebi fb="0" ids="6104">kanamycin</z:chebi> and <z:chebi fb="0" ids="28487">reserpine</z:chebi> were found useful for decreasing the postoperative complications of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
</text></document>